Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 243 Jul 27 – Oct 24, 2026
- Disclosed funding
- $6.3B 177 disclosed amounts
- Median round
- $14.2M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| I ImplicityCompany profile Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices. Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices. | €35M | Growth equityGrowth | Healthtech | France | Investors | |
| AL Anemo LabsCompany profile Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. | £700K | Pre-seed | Healthtech | United Kingdom | Investors | |
| VH Verily HealthCompany profile An AI-native precision-health platform organizes complex health data for research, care and personalized health services. An AI-native precision-health platform organizes complex health data for research, care and personalized health services. | Undisclosed | March financing extensionUndisclosed | Healthtech | United States | Investors | |
| NM Neurent MedicalCompany profile Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. | $25M | Growth investmentGrowth | Healthtech | Ireland | Investors | |
| CI ClaimQI, Inc.Company profile Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language. Claims-intelligence software that helps health plans review and prevent improper payments against coverage rules and policy language. | ~$500K | Seed | Healthtech | United States | Investors | |
| 3 3SonicCompany profile Portable 3D ultrasound for assessing a removed tumour’s margins during cancer surgery. Portable 3D ultrasound for assessing a removed tumour’s margins during cancer surgery. | €1.3M | BII additional fundingUndisclosed | Healthtech | Denmark | Investors | |
| HC Hope CareCompany profile Hope Care provides a regulated remote-patient-monitoring platform to health systems and care providers. Its OpMA platform brings patient-reported and connected-device measurements into clinical programmes, where care teams review dashboards and alerts, follow patients remotely and intervene when readings indicate deterioration. Hope Care provides a regulated remote-patient-monitoring platform to health systems and care providers. Its OpMA platform brings patient-reported and connected-device measurements into clinical programmes, where care teams review dashboards and alerts, follow patients remotely and intervene when readings indicate deterioration. | €6M | Series A | Healthtech | Portugal | Investors | |
| DM Deneb MedicalCompany profile Deneb Medical is developing IZAR, a robotic spine-surgery station that supports surgeons from preoperative planning through image-based registration, screw placement and laser tissue ablation. The system combines robotic navigation, imaging, photonics and software to make spine procedures more precise and repeatable while fitting into the operating-room workflow. Deneb Medical is developing IZAR, a robotic spine-surgery station that supports surgeons from preoperative planning through image-based registration, screw placement and laser tissue ablation. The system combines robotic navigation, imaging, photonics and software to make spine procedures more precise and repeatable while fitting into the operating-room workflow. | €14.7M | Capital increaseUndisclosed | Healthtech | Spain | Investors | |
| F ForusCompany profile Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows. Connects healthcare providers, pharmacies, payers and biopharma through AI-assisted treatment-access workflows. | $150M | Series CSeries C+ | Healthtech | United States | Investors | |
| V VaxdynCompany profile Vaxdyn develops vaccines against antimicrobial-resistant bacteria, including its lead candidate K-VAX for Klebsiella pneumoniae and Acinetobacter baumannii. Vaxdyn develops vaccines against antimicrobial-resistant bacteria, including its lead candidate K-VAX for Klebsiella pneumoniae and Acinetobacter baumannii. | €11M | Series A | Healthtech, Biotech | Spain | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jul 27, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
6rounds1led - 2Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
6rounds2led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
5rounds0led - 4Y Combinator (YC)
Vitalize, Angle Health, Metriport
5rounds0led - 5European Investment Bank
HighLife, MMI, Tensive
5rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.